Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry
Background: In atopic dermatitis (AD), the real-world impact of achieving itch and skin lesion treatment targets compared to partial improvement remains unclear.Objective: We assessed the relationship between itch relief (reduction in Worst Itch Numeric Rating Scale [WI-NRS]) and skin clearance (Inv...
Saved in:
| Main Authors: | Jonathan I. Silverberg, Brian M. Calimlim, Ayman Grada, Christopher G. Bunick, Melinda J. Gooderham, Vivian Y. Shi, Chibuzo Obi, Keith D. Knapp, Breda Munoz, Julie M. Crawford, Amy S. Paller |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2024.2428729 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis
by: Teppei Hagino, et al.
Published: (2024-12-01) -
Chronic Itch Among Soldiers and Civilians: A Cross-sectional Study During the War in Ukraine
by: Jacek C. Szepietowski, et al.
Published: (2025-03-01) -
The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA)
by: Jennifer Soung, et al.
Published: (2025-07-01) -
Measuring itch occurrence in various chronic pain conditions: across sectional study
by: Wael Saleem, et al.
Published: (2024-04-01) -
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis
by: Eric L. Simpson, et al.
Published: (2025-06-01)